Log In
BCIQ
Print this Print this
 

NT-125

  Manage Alerts
Collapse Summary General Information
Company Kanion Pharmaceutical Co. Ltd.
DescriptionAn oral small molecule inhibitor of poly(ADP-ribose) polymerase (PARP)
Molecular Target Poly(ADP-ribose) polymerase (PARP)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/02/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today